Apadamtase Alfa: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Apadamtase Alfa. Educational only — not medical advice.
Labeled uses
ADZYNMA (ADAMTS13, recombinant-krhn) is a human recombinant “A disintegrin and metalloproteinase with thrombospondin motifs 13” (rADAMTS13) indicated for prophylactic or on demand enzyme replacement therapy (ERT) in adult and pediatric patients with congenital thrombotic thrombocytopenic purpura (cTTP) [see Use in Specific Populations (8.4) , Clinical Studies (14) ].
Source: FDA labeling via NIH DailyMed (set 22728e96…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.